title: Resolution of granuloma annulare following treatment with bendamustine and rituximab in a patient with follicular lymphoma: a serendipitous finding.
abstract: Granuloma annulare is a benign inflammatory dermatosis. Cell-mediated immunity and delayed hypersensitivity are proposed pathogenic mechanisms. We report in this paper a case of generalized granuloma annulare that resolved after the patient was treated with rituximab and bendamustine for stage IV follicular lymphoma.
authors.affiliation: Cancer Center and Blood Institute, Idaho, United States, USA.
authors.forename: B K
authors.initials: BK
authors.lastname: Shah
authors.forename: Y
authors.initials: Y
authors.lastname: Hewett
authors.forename: A
authors.initials: A
authors.lastname: Peterson
authors.forename: D
authors.initials: D
authors.lastname: Tretheway
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage* / Q000627:therapeutic use; D000069461:Bendamustine Hydrochloride; D005260:Female; D016460:Granuloma Annulare / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage*; D008224:Lymphoma, Follicular / Q000150:complications* / Q000473:pathology; D009367:Neoplasm Staging; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage* / Q000627:therapeutic use; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D009588:Nitrogen Mustard Compounds; D000069283:Rituximab; D000069461:Bendamustine Hydrochloride